Though, when only looking at the patients with a log2 fold increase >0.5 of the CD3D gene, a significant increase in the CD36 and CD44 gene expression at the tumor site was revealed (p = 0.0198 and p = 0.0479, respectively, Wilcoxon ranked t-test) (Figure 6B,C)—indicating that these genes were upregulated in patients with increased T cell infiltration. Here, CD3D is linked to neoplasm.